CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

The Two Key Trends Of AI In Biotechnology

The Two Key Trends Of AI In...

Compound K', Is Fast Absorbing And Has A Higher Immune-Boosting Effect Than Ginseng

Compound K', Is Fast Absorbing And...

Informa Pharma Intelligence announces the launch of its Citeline Connect

Informa Pharma Intelligence announces...

Industry Giants Say Covid-19 Offers A 'Significant Opportunity' To Fast-Track Cancer Eradication

Industry Giants Say Covid-19 Offers A...

How Does Biotechnology Help the World

How Does Biotechnology Help the World

Pharma and Biotech are Looking to Cloud and AI to Expediate Drug Discovery

Pharma and Biotech are Looking to...

Advantages of Biotech Partnership

Advantages of Biotech Partnership

How AI Enhances Biotech Operations

How AI Enhances Biotech Operations

The Two Key Trends Of AI In Biotechnology

The Two Key Trends Of AI In...

Compound K', Is Fast Absorbing And Has A Higher Immune-Boosting Effect Than Ginseng

Compound K', Is Fast Absorbing And...

Informa Pharma Intelligence announces the launch of its Citeline Connect

Informa Pharma Intelligence announces...

Industry Giants Say Covid-19 Offers A 'Significant Opportunity' To Fast-Track Cancer Eradication

Industry Giants Say Covid-19 Offers A...

How Does Biotechnology Help the World

How Does Biotechnology Help the World

Pharma and Biotech are Looking to Cloud and AI to Expediate Drug Discovery

Pharma and Biotech are Looking to...

Advantages of Biotech Partnership

Advantages of Biotech Partnership

How AI Enhances Biotech Operations

How AI Enhances Biotech Operations

Major Factors Revamping Asian Biopharma Supply Chain

Life Sciences Review | Tuesday, August 24, 2021
Tweet

The landscape is changing rapidly for Asia’s biopharma sector, which has been thrust to the center of the battle against COVID-19.


FREMONT, CA: Most pharma have complex supply chains under-utilized, inefficient and ill-armed to cope with the sort of products coming down the pipeline. A new report predicts that to meet the demands of a fast-evolving marketplace and the transformation from patient to outcome, the pharma supply chain will require a radical overhaul. Several forces are reshaping the environment in which the sector operates and dictating the need for a different supply chain. Here are some major trends that are shaping the Asian biopharma supply chain. 



  • Making Medicines Faster and Cheaper 


Making medicines faster and cheaper is a new normal. But against the debate on quality and cost, the broader innovation is only accelerating. As big global firms ramp up output, the requirement for technology that boosts productivity should grow. Smaller companies are stepping up to take bigger roles. The objective to bring new products to market faster is reflected across Asia. There is major investment across all sub-sectors of healthcare start-ups, comprising med-tech and biopharma, where players are expected in fields like the cell, gene therapies and small molecules.



  • Environmental-Friendly Packaging


Consumers are now expecting products manufactured and delivered through sustainable processes from sustainable firms. And while pharma packaging presents waste issues, more sustainable solutions are on the rise, especially in the most challenging temperature range to sustain. Similarly, active temperature-controlled speciality containers, which avoid the need for gel packs or dry ice, will remain in demand – especially for transporting temperature-sensitive active pharmaceutical ingredients.



  • Better Manufacturing Agility


As the race to discover, develop and market medicine increases, examples of differentiated, value-specific supply chains for various product types appear everywhere. The COVID-19 pandemic highlighted the need for agility. Fears over severe shortages of antibiotics and medicines have increased. With the prolonged closure of China’s factories, the vulnerability of the pharma supply chain became evident. The pharma supply chain, including biopharma, will need the flexibility to manage its supply chain.


See Also :- Top Tech Solutions for Healthcare


Weekly Brief

loading
Top 10 Biotech Startups in APAC - 2022
> <
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue

Read Also

Qualities to Consider when Choosing Life Sciences Business Consultants for Your Firm

How Biotech Startups can Mitigate Risks in Order to Grow Sustainably

Cellf BIO's BioShincter to Undergo Phase 1 Trail to Test Fecal Incontinence Treatment

Fulcrum Therapeutics Announces CEO Transition

An Overview of Wholesalers' Roles in Complex Supply Chains

Veeva Opening Up Integration Module for Future Opportunities and Applications

Veeva Systems To Accelerate the CRM of Life Science Businesses

The Role of Technology in Advancing Clinical Trials

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/major-factors-revamping-asian-biopharma-supply-chain-nwid-301.html